Aplysiatoxin
![]() | |
| Names | |
|---|---|
| Other names
Aplysiatoxin
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C32H47BrO10 | |
| Molar mass | 671.614 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
Aplysiatoxin is a cyanotoxin produced by certain cyanobacteria species. It is used as a defensive secretion to protect these cyanobacteria from predation by fish, being a potent irritant and carcinogen, by acting as a powerful activator of protein kinase C.[1][2][3][4] While this action has a tumour-promoting effect, protein kinase C activation can be medically beneficial for some other applications, and synthetic analogues of aplysiatoxin have been researched for anti-cancer effects.[5][6][7]
See also
References
- ^ Kato, Y; Scheuer, PJ (Apr 1974). "Aplysiatoxin and debromoaplysiatoxin, constituents of the marine mollusk Stylocheilus longicauda (Quoy and Gaimard, 1824)". Journal of the American Chemical Society. 96 (7): 2245–6. doi:10.1021/ja00814a041. PMID 4833645.
- ^ Weinstein, IB; Arcoleo, J; Backer, J; et al. (1983). "Molecular mechanisms of tumor promotion and multistage carcinogenesis". Int. Symp. Princess Takamatsu Cancer Res. Fund. 14: 59–74. PMID 6097583.
- ^ Arcoleo, JP; Weinstein, IB (Feb 1985). "Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium". Carcinogenesis. 6 (2): 213–7. doi:10.1093/carcin/6.2.213. PMID 3156004.
- ^ Nagai, H; Yasumoto, T; Hokama, Y (Jul 1996). "Aplysiatoxin and debromoaplysiatoxin as the causative agents of a red alga Gracilaria coronopifolia poisoning in Hawaii". Toxicon. 34 (7): 753–61. doi:10.1016/0041-0101(96)00014-1. PMID 8843576.
- ^ Watanabe, M; Kawase, Y; Tanabe, J; Min, KR; Mue, S; Ohuchi, K (Feb 1995). "Suppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells". Journal of Pharmacology and Experimental Therapeutics. 272 (2): 808–14. PMID 7853198.
- ^ Nakagawa, Y; Yanagita, RC; Hamada, N; Murakami, A; Takahashi, H; Saito, N; Nagai, H; Irie, K (Jun 2009). "A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activity". Journal of the American Chemical Society. 131 (22): 7573–9. doi:10.1021/ja808447r. PMID 19449873.
- ^ Yanagita, RC; Kamachi, H; Tanaka, K; Murakami, A; Nakagawa, Y; Tokuda, H; Nagai, H; Irie, K (Oct 2010). "Role of the phenolic hydroxyl group in the biological activities of simplified analogue of aplysiatoxin with antiproliferative activity". Bioorganic & Medicinal Chemistry Letters. 20 (20): 6064–6. doi:10.1016/j.bmcl.2010.08.051. PMID 20817520.
